Clinical trial
Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by…
NCT00463749 · University of Leipzig, Other · Completed
Key facts
| NCT number | NCT00463749 |
|---|---|
| Title | Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by N-Acetylcystein |
| Official title | Trial to Compare Infarct Size and Occurrence of Contrast Dye Induced Nephropathy in Patients With Primary Percutaneous PCI in STEMI |
| Acronym | LIPSIA-N-ACC |
| Lead sponsor | University of Leipzig, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Acetylcystein, Placebo |
| Enrollment | 251 |
| Start date | Dec 1, 2006 |
| Primary completion | Feb 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Apr 20, 2007 |
| Last update posted | Jul 8, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: